ECM
SRGA

ExodusPoint Capital Management’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

ExodusPoint Capital Management’s Portfolio SRGA Stock Details SRGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,049
Closed -$67K – 2789
2021
Q3 		$67K Buy
2,049
+604
+42% +$22.1K ﹤0.01% 1951
2021
Q2 		$60K Buy
+1,445
New +$74K ﹤0.01% 2206
2019
Q2 		– Sell
-1,096
Closed -$198K – 1417
2019
Q1 		$198K Buy
+1,096
New +$159K 0.01% 567

Other funds holding SRGA

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return
CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

ExodusPoint Capital Management's SRGA Position: Q4 2021 in Review

ExodusPoint Capital Management sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q4 2021, closing a stake of 2,049 shares — an estimated $67K sold.

ExodusPoint Capital Management first reported a position in SRGA in Q1 2019 and held it in 3 quarters. The position peaked at $198K in Q1 2019. 72 funds tracked by Wall St. Rank hold SRGA as of Q4 2021.

  • ExodusPoint Capital Management reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • ExodusPoint Capital Management sold 2,049 Surgalign Holdings, Inc. Common Stock shares in Q4 2021, an estimated $67K.
  • ExodusPoint Capital Management first reported a position in Surgalign Holdings, Inc. Common Stock in Q1 2019 and held it in 3 quarters.
  • ExodusPoint Capital Management's Surgalign Holdings, Inc. Common Stock position peaked at $198K in Q1 2019.
  • 72 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q4 2021.

Based on ExodusPoint Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.